TrialAmerican journal of respiratory and critical care medicine2017

Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.

Kenneth N Olivier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.